The research investigates how intestinal epithelial GSK3β drives the polarization and reprogramming of tumor-infiltrating neutrophils (TINs) in colorectal cancer. Using advanced multiomics profiling and mouse models, the authors demonstrate that GSK3β deficiency suppresses the development of immunosuppressive T3 neutrophils, which typically promote tumor growth, ferroptosis resistance, and immune evasion. Mechanistically, this regulation relies on a metabolic-epigenetic axis involving lactate-driven fumarate accumulation and histone modification changes within the tumor microenvironment. Furthermore, the study highlights that pharmacological GSK3β inhibition using tideglusib successfully hinders T3 neutrophil polarization and improves the effectiveness of checkpoint blockade immunotherapy. Ultimately, these findings establish a critical link between epithelial signaling and immune cell plasticity, offering promising avenues for combinatorial CRC therapies.
References:
He X S, Yang X Q, Wan S, et al. Intestinal epithelial GSK3β governs fumarate-dependent neutrophil reprogramming to promote colorectal cancer[J]. Nature Cancer, 2026: 1-22.

